Sabella Lauren M

Avg. Two Year Performance

No purchase track record
10% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return4%10%23%12%10%
Sale Success Rate5 of 135 of 138 of 134 of 135 of 13
Drugs » Biotechnology

Chief Commercial Officer:

Holdings: 12.62K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

VP of Commercial Development:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--